1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF NEPHRITIS TREATMENT MEDICINES MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL NEPHRITIS TREATMENT MEDICINES MARKET SNAPSHOT
3.2 GLOBAL NEPHRITIS TREATMENT MEDICINES MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL NEPHRITIS TREATMENT MEDICINES MARKET, BY TYPE
5.1 OVERVIEW
5.2 CORTICOSTEROIDS
5.3 IMMUNOSUPPRESIVE DRUGS
6 GLOBAL NEPHRITIS TREATMENT MEDICINES MARKET, BY GEOGRAPHY
6.1 NORTH AMERICA
6.1.1 MARKET DYNAMICS
6.1.1.1 DRIVERS
6.1.1.2 RESTRAINS
6.1.1.3 OPPORTUNITY
6.1.2 U.S.
6.1.3 CANADA
6.1.4 MEXICO
6.2 EUROPE
6.2.1 MARKET DYNAMICS
6.2.1.1 DRIVERS
6.2.1.2 RESTRAINS
6.2.1.3 OPPORTUNITY
6.2.2 U.K.
6.2.3 FRANCE
6.2.4 GERMANY
6.2.5 REST OF EUROPE
6.3 ASIA PACIFIC
6.3.1 MARKET DYNAMICS
6.3.1.1 DRIVERS
6.3.1.2 RESTRAINS
6.3.1.3 OPPORTUNITY
6.3.2 INDIA
6.3.3 CHINA
6.3.4 JAPAN
6.3.5 REST OF ASIA PACIFIC
6.4 MIDDLE EAST AND AFRICA
6.4.1 MARKET DYNAMICS
6.4.1.1 DRIVERS
6.4.1.2 RESTRAINS
6.4.1.3 OPPORTUNITY
6.4.2 SOUTH AFRICA
6.4.3 REST OF MIDDLE EAST AND AFRICA
6.5 LATIN AMERICA
6.5.1 MARKET DYNAMICS
6.5.1.1 DRIVERS
6.5.1.2 RESTRAINS
6.5.1.3 OPPORTUNITY
6.5.2 BRAZIL
6.5.3 REST OF LATIN AMERICA
7 COMPETATIVE LANDSCAPE
7.1 OVERVIEW
7.2 NEW PRODUCT LAUNCHES
8 GLOBAL NEPHRITIS TREATMENT MEDICINES MARKET, BY COMPANY
8.1 INTRODUCTION
8.2 ASTRAZENECA
8.2.1 BUSINESS OVERVIEW
8.2.2 PRODUCTS & SERVICES
8.2.3 KEY STRATEGY
8.2.4 RECENT DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.3 ROCHE HOLDING AG
8.3.1 BUSINESS OVERVIEW
8.3.2 PRODUCTS & SERVICES
8.3.3 KEY STRATEGY
8.3.4 RECENT DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.4 AURINIA PHARMACEUTICALS INC.
8.4.1 BUSINESS OVERVIEW
8.4.2 PRODUCTS & SERVICES
8.4.3 KEY STRATEGY
8.4.4 RECENT DEVELOPMENTS
8.4.5 SWOT ANALYSIS
8.5 BRISTOL-MYERS SQUIBB
8.5.1 BUSINESS OVERVIEW
8.5.2 PRODUCTS & SERVICES
8.5.3 KEY STRATEGY
8.5.4 RECENT DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.6 GLAXOSMITHKLINE PLC
8.6.1 BUSINESS OVERVIEW
8.6.2 PRODUCTS & SERVICES
8.6.3 KEY STRATEGY
8.6.4 RECENT DEVELOPMENTS
8.6.5 SWOT ANALYSIS
8.7 MERCK & CO.
8.7.1 BUSINESS OVERVIEW
8.7.2 PRODUCTS & SERVICES
8.7.3 KEY STRATEGY
8.7.4 RECENT DEVELOPMENTS
8.7.5 SWOT ANALYSIS